As of mid-2026, neither is FDA- or EMA-approved
Non-Invasive and Convenient: Peptide therapy is a non-surgical treatment that is minimally invasive and doesnt require long recovery periods, making it a convenient option for those looking to lose fat without the risks associated with surgery
BPC-157 is not FDA-approved to treat, cure, or prevent any disease
But some users do report mild side effects, including: Headaches or dizziness (typically at higher doses or when stacking with GH-related peptides) Injection site irritation , redness, or swelling Nausea or GI discomfort when taken orally (more common with low-quality forms) Changes in mood or energy , including restlessness or mild anxiety These symptoms are usually temporary and resolve quickly with dosage adjustment or cycling off
J Geriatr Psychiatry Neurol 2020;33(4):185194
We recommend using it within this timeframe for the most reliable research results